1. Mulberg AE, Bucci-Rechtweg C, Giuliano J, Jacoby D, Johnson FK, Liu Q , et al. Regulatory strategies for rare diseases under current global regulatory statutes: A discussion with stakeholders. Orphanet Journal of Rare Diseases. 2019;14(1):36
2. Might M, Wilsey M. The shifting model in clinical diagnostics: How next-generation sequencing and families are altering the way rare diseases are discovered, studied, and treated. Genetics in Medicine. 2014;16(10):736-737
3. Wright CF, FitzPatrick DR, Firth HV. Paediatric genomics: Diagnosing rare disease in children. Nature Reviews Genetics. 2018;19(5):253-268
4. CADTH. Genome-wide sequencing: ethical considerations [Internet]. 12 November 2019. 37 p. Available from: https://www.cadth.ca/sites/default/files/hta-he/he0020-genome-wide-sequencing-ethical-considerations.pdf [cited: 17 December 2019]
5. National Institutes of Health. DRAFT NIH Policy for data management and sharing [Internet]. November 2019. 4 p. Available from: https://osp.od.nih.gov/wp-content/uploads/Draft_NIH_Policy_Data_Management_and_Sharing.pdf [cited: 17 December 2019]